Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alessandro Russo, Paolo Fusco, Helen Linda Morrone, Enrico Maria Trecarichi & Carlo Torti. (2023) New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae. Expert Review of Anti-infective Therapy 21:1, pages 41-55.
Read now
Read now
Matteo Bassetti, Antonio Falletta, Giovanni Cenderello, Daniele R. Giacobbe & Antonio Vena. (2022) Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infections. Expert Opinion on Drug Safety 21:4, pages 487-498.
Read now
Read now
Alessandro Russo, Marco Berruti, Daniele Roberto Giacobbe, Antonio Vena & Matteo Bassetti. (2021) Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria. Expert Review of Anti-infective Therapy 19:8, pages 983-991.
Read now
Read now
Matteo Bassetti, Maddalena Peghin, Alessio Mesini & Elio Castagnola. (2020) Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam. Infection and Drug Resistance 13, pages 1763-1773.
Read now
Read now
Articles from other publishers (22)
Dongliang Guan, Jian Li, Feifei Chen, Jiaqi Li, Xiaolei Bian, Yue Yu, Xinxin Feng, Lefu Lan & Wei Huang. (2023) A facile and selective derivatization approach on kynurenine-NH2 in daptomycin, leading to the discovery of hexakynomycin to combat multidrug-resistant Gram-positive pathogens especially daptomycin-resistant bacteria. European Journal of Medicinal Chemistry 259, pages 115638.
Crossref
Crossref
Yunxiang Yan, Yong Liu, Juanjuan Li, Ye Li, Haoheng Wu, Hong Li, Xiang Ma, Yanqiong Tang, Yuan Tong, Kexian Yi, Quanfeng Liang & Zhu Liu. (2023) A Molecular Switch‐Integrated Nanoplatform Enables Photo‐Unlocked Antibacterial Drug Delivery for Synergistic Abscess Therapy. Advanced Healthcare Materials 12:27.
Crossref
Crossref
Bruna Renata SilvaPaula Assis QueirozPedro Henrique Rodrigues do AmaralBeatriz Cardoso de FreitasAlison Fernando StoccoEloisa Gibin SampironFábio VandresenMaria Cristina Bronharo TognimKatiany Rizzieri Caleffi-FerracioliRegiane Bertin de Lima ScodroRosilene Fressatti CardosoFelipe de Almeida La PortaVera Lucia Dias Siqueira. (2022)
Polymyxin B Activity Rescue by (−)-Camphene-Based Thiosemicarbazide Against Carbapenem-Resistant
Enterobacterales
. Microbial Drug Resistance 28:10, pages 962-971.
Crossref
Crossref
Alessandro Russo, Francesca Serapide, Angela Quirino, Maria Grazia Tarsitano, Nadia Marascio, Riccardo Serraino, Salvatore Rotundo, Giovanni Matera, Enrico Maria Trecarichi & Carlo Torti. (2022) Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota. Diagnostics 12:9, pages 2143.
Crossref
Crossref
Shani Feldman, Alessandro Russo, Giancarlo Ceccarelli, Cristian Borrazzo, Chiara Madge, Mario Venditti & Manuela Merli. (2022) Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis. Journal of Clinical and Experimental Hepatology 12:5, pages 1293-1300.
Crossref
Crossref
Alessandro Russo, Vincenzo Olivadese, Enrico Trecarichi & Carlo Torti. (2022) Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic. Journal of Clinical Medicine 11:9, pages 2279.
Crossref
Crossref
Alessandro Lazzaro, Gabriella De Girolamo, Valeria Filippi, Giuseppe Pietro Innocenti, Letizia Santinelli, Giancarlo Ceccarelli, Enrico Maria Trecarichi, Carlo Torti, Claudio Maria Mastroianni, Gabriella d’Ettorre & Alessandro Russo. (2022) The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review. International Journal of Molecular Sciences 23:2, pages 803.
Crossref
Crossref
Alessandro Russo, David L. Paterson & Matteo Bassetti. (2021) Editorial: Spotlight on the Relationship Between Sepsis and Infection: From Mechanisms to Therapy. Frontiers in Medicine 8.
Crossref
Crossref
J. Belkhair, S. Nachat, S. Rouhi, H. Ouassif, S. Abbassi & N. Soraa. (2021) Evaluation of in vitro activity of ceftolozane-tazobactam in combination with other classes of antibacterial agents against Enterobacterales and Pseudomonas aeruginosa—the EM200 study. New Microbes and New Infections 41, pages 100872.
Crossref
Crossref
Matteo Bassetti, Antonio Vena, Alessandro Russo & Maddalena Peghin. (2020) Inhaled Liposomal Antimicrobial Delivery in Lung Infections. Drugs 80:13, pages 1309-1318.
Crossref
Crossref
Hoi Yee Chow, Kathy Hiu Laam Po, Peng Gao, Pilar Blasco, Xiukun Wang, Congran Li, Lianwei Ye, Kang Jin, Kaichao Chen, Edward Wai Chi Chan, Xuefu You, Richard Yi Tsun Kao, Sheng Chen & Xuechen Li. (2020) Methylation of Daptomycin Leading to the Discovery of Kynomycin, a Cyclic Lipodepsipeptide Active against Resistant Pathogens. Journal of Medicinal Chemistry 63:6, pages 3161-3171.
Crossref
Crossref
Felipe Francisco Tuon, Juliette Cieslinski, Suellen da Silva Rodrigues, Fernando Brandão Serra & Marina Della-Negra de Paula. (2020) Evaluation of in vitro activity of ceftolozane–tazobactam against recent clinical bacterial isolates from Brazil – the EM200 study. The Brazilian Journal of Infectious Diseases 24:2, pages 96-103.
Crossref
Crossref
Priscila R. Oliveira, Vladimir C. Carvalho, Eduardo S. Saconi, Marcos C. Leonhardt, Kodi E. Kojima, Jorge S. Santos, Flavia Rossi & Ana Lucia L.M.. (2020) Tigecycline Versus Colistin in the Treatment of Carbapenem-resistant Acinetobacter baumannii Complex Osteomyelitis. Journal of Bone and Joint Infection 5:2, pages 60-66.
Crossref
Crossref
Ian Morrissey, Melanie Olesky, Stephen Hawser, Sibylle H. Lob, James A. Karlowsky, G. Ralph Corey, Matteo Bassetti & Corey Fyfe. (2020)
In Vitro
Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017
. Antimicrobial Agents and Chemotherapy 64:3.
Crossref
Crossref
Nontombi Marylucy Mbelle, Charles Feldman, John Osei Sekyere, Nontuthuko Excellent Maningi, Lesedi Modipane & Sabiha Yusuf Essack. (2020) Pathogenomics and Evolutionary Epidemiology of Multi-Drug Resistant Clinical Klebsiella pneumoniae Isolated from Pretoria, South Africa. Scientific Reports 10:1.
Crossref
Crossref
Joseph John Jr. (2020) The treatment of resistant staphylococcal infections. F1000Research 9, pages 150.
Crossref
Crossref
Bojjibabu Chidipi, Samuel Ignatious Bolleddu, Achanta Jagadeesh & Alalvala Mattareddy. 2020. Nanostructures for Antimicrobial and Antibiofilm Applications. Nanostructures for Antimicrobial and Antibiofilm Applications
399
415
.
Silvia Corcione, Tommaso Lupia, Alberto Enrico Maraolo, Simone Mornese Pinna, Ivan Gentile & Francesco G. De Rosa. (2019) Carbapenem-sparing strategy. Current Opinion in Infectious Diseases 32:6, pages 663-673.
Crossref
Crossref
Paola Del Giacomo, Angela Raffaella Losito & Mario Tumbarello. (2019) The role of carbapenem-resistant pathogens in cSSTI and how to manage them. Current Opinion in Infectious Diseases 32:2, pages 113-122.
Crossref
Crossref
Miranda E Pitt, Minh Duc Cao, Mark S Butler, Soumya Ramu, Devika Ganesamoorthy, Mark A T Blaskovich, Lachlan J M Coin & Matthew A Cooper. (2019)
Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR
Klebsiella pneumoniae
ST258 isolate
. Journal of Antimicrobial Chemotherapy 74:3, pages 582-593.
Crossref
Crossref
Mario Tumbarello, Angela Raffaella Losito & Helen Giamarellou. (2018) Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections. Current Opinion in Infectious Diseases 31:6, pages 566-577.
Crossref
Crossref
Elda Righi. (2018) Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions. World Journal of Gastroenterology 24:38, pages 4311-4329.
Crossref
Crossref